•   
  •   

US News Positive ChMP Review For a form of a lung cancer treatment

20:20  17 september  2021
20:20  17 september  2021 Source:   ouest-france.fr

"I love you and I will always love you": The upsetting tribute of Loïc (Koh-Lanta, Legend) in Bertrand-Kamal, one year after his death

 © Instagram Loic Koh-Lanta "I Love and I will always love you ": the upsetting tribute of Loïc (Koh-Lanta, Legend) in Bertrand-Kamal, one year after his death on September 9th 2020, died Bertrand-Kamal, iconic candidate of Koh-Lanta : The 4 lands, cancer suites. A year just after her disappearance, her friend Loïc made her upsetting tribute on Instagram.

Une photo montrant le logo du géant pharmaceutique suisse Roche à son siège à Bâle, le 17 février 2015. © Sebastien Bozon / ARCHIVE AFP A photo showing the Logo of the Swiss Pharmaceutical Giant Roche at its headquarters in Basel, February 17, 2015.

The CHMP, In charge of examining drugs that can be marketed in the European Union, has made a positive opinion concerning Gavreto, a new treatment for a form of lung cancer.

The Human Drugs Committee (CHMP), made a positive opinion on Gavreto, a new treatment for a lung cancer form, announced Friday 17 September the Swiss Pharmaceutical Group Roche .

The European Commission should align

this body responsible for examining drugs that can be marketed in the European Union has voted in its favor for adult patients with an advanced form of lung cancer. Small cells with mergers of the RET gene, indicated the Swiss group in a statement.

Twenty years later, America pays tribute to the 3,000 deaths of 11-September

 Twenty years later, America pays tribute to the 3,000 deaths of 11-September © AFP The America commemorates Saturday the twenty years of the 11-September during memorial and solemn ceremonies of tribute to some 3,000 deaths Attacks of al-Qaeda , in an atmosphere increased by the Chaotic American withdrawal of Afghanistan .

The European Commission, which is for its part to approve the drugs, generally aligns with its recommendations within two months.

Developed with the American Laboratory Blueprint Medicines, this treatment also called PRALSETINIB makes it possible to treat patients with this rare form of lung cancer.

37,500 patients a year

It affects about 37,500 people per year at the global level and is often diagnosed in young patients who have little or never smoked, says rock, the world's number one oncology.

These alterations of the RET gene are factors of evolution of the disease, particularly for lung cancer and different forms of thyroid cancer.

The treatment was first approved in the United States in September 2020 for adult patients with this form of lung cancer before the US agency also does not agree in December for its use in cancer of the Thyroid for adult patients and children aged 12 and over.

In order to complement its range of drugs in lung cancers, Roche had sealed an agreement with Blueprint Medicines in July 2020 to market this treatment.

Chile: a new spine in the foot of the Constituent Assembly .
© Juan Carlos Canino / SegPres, AFP The Chilean Constituent Assembly began its work in July 2021. Here, at its first session, on July 7, 2021 ; in Santiago. In Chile, the Constituent Assembly began its work two and a half months ago, and it should adopt its settlement by this month, that is, the specific framework in which the elected officials will write the new Constitution.

usr: 0
This is interesting!